Viewing Study NCT04481932


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT04481932
Status: RECRUITING
Last Update Posted: 2020-07-22
First Post: 2020-07-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module